Barclays sees roughly 60% upside in Boeing, but the thesis depends on turning higher aircraft deliveries into durable free cash flow while costly defense programs and execution risk remain.
Barclays has put a $300 price target on Boeing, a level about 60% above the stock's October 15 close of $187.22. The target is eye-catching, but the underlying question is simpler: can Boeing convert a healthier delivery cadence into sustained cash flow while containing losses on troubled defense programs?
The latest company results offer evidence for both the upside case and the caution. Boeing delivered 171 commercial aircraft in the second quarter, helping lift revenue to $24.6 billion and produce $631 million of free cash flow. That was a meaningful improvement for a company whose recovery has repeatedly been delayed by production, quality and certification problems. Commercial Airplanes revenue reached $11.8 billion, although the division still posted a negative 2.7% operating margin.
The defense portfolio remains a visible drag. Boeing recorded another $280 million loss on the VC-25B presidential aircraft program as it added production and certification resources. Companywide, Boeing still reported a GAAP loss of $0.67 per share and a core loss of $0.76 per share. Those figures matter because a higher delivery rate does not automatically repair fixed-price defense contracts or eliminate execution costs.
Barclays' target therefore asks investors to look through near-term losses and value Boeing on a normalized earnings and cash-flow base. The original report cited consensus estimates moving from a loss in 2026 to positive earnings in 2027 and a stronger result in 2028. Those estimates are not company guidance, and their usefulness depends on production stability, supplier performance and regulatory progress.
The stock's roughly 26% decline from its January high gives the recovery thesis more room to work, but it also reflects the market's skepticism. The $300 target is credible only if deliveries translate into repeatable cash generation rather than another temporary improvement.
Boeing's next earnings report is the nearest test. Investors should focus less on a single adjusted earnings number than on commercial deliveries, free cash flow, 737 and 787 production discipline, and fresh charges on fixed-price defense contracts. A recovery that improves all four would support Barclays' valuation. A recovery driven mainly by optimistic out-year estimates would not.
Research and commentary are provided for information, not personalized investment advice. Verify material claims with the linked source and original company disclosures. Report a correction · About BTI
